• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

夜尿症及其对德国50岁及以上社区居住男性健康相关生活质量和就医行为的影响。

Nocturia and its impact on health-related quality of life and health care seeking behaviour in German community-dwelling men aged 50 years or older.

作者信息

Oelke Matthias, Wiese Birgitt, Berges Richard

机构信息

Department of Urology, OE 6240, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany,

出版信息

World J Urol. 2014 Oct;32(5):1155-62. doi: 10.1007/s00345-014-1374-6. Epub 2014 Aug 8.

DOI:10.1007/s00345-014-1374-6
PMID:25103609
Abstract

PURPOSE

To evaluate the prevalence of nocturia/nocturnal voiding frequency and its impact on overall physical and mental health status in German community-dwelling men and determine which lower urinary tract symptom (LUTS) is responsible for medical consultations in the 2-year follow-up period.

METHODS

A sample of German men aged 50-80 years from a community-dwelling study was chosen for re-evaluation 2 years after initial assessment. Men were clinically investigated and completed the International Prostate Symptom Score, American Urology Association-Symptom Problem Index (AUA-SPI), and the Short-Form Health Survey (SF-12).

RESULTS

In total, 1,562 men were eligible for analysis. Mean nocturnal voiding frequency was 2.3 for all men and increased with ageing. SF-12 data indicated that physical but not mental health status was lower than in the average population. LUTS severity reduced both physical and mental health status (p < 0.001). Clinically relevant nocturia (≥ 2 voids/night) was present in 43 % of men and reduced both physical and mental health status (p < 0.001), whereas both HRQoL scales were not significantly reduced in men without or only one nocturnal void. In multivariate regression analysis using patient-reported bother (AUA-SPI) from LUTS, only bother from nocturnal voiding was significantly associated with medical consultations in the investigated 2-year follow-up period (odds ratio 2.6; 95 % confidence interval 1.6-4.2; p < 0.001).

CONCLUSIONS

Our study confirmed that nocturnal voiding is highly prevalent in community-dwelling men and reduce both physical and mental health status. Bother from nocturnal voiding is the most relevant component of LUTS responsible for medical consultations in German men.

摘要

目的

评估德国社区男性夜尿症/夜间排尿频率的患病率及其对整体身心健康状况的影响,并确定在2年随访期内导致就医的下尿路症状(LUTS)。

方法

从一项社区居住研究中选取年龄在50 - 80岁的德国男性样本,在初次评估2年后进行重新评估。对男性进行临床检查,并完成国际前列腺症状评分、美国泌尿外科学会症状问题指数(AUA - SPI)和简短健康调查(SF - 12)。

结果

共有1562名男性符合分析条件。所有男性的平均夜间排尿频率为2.3次,且随年龄增长而增加。SF - 12数据表明,身体健康状况而非心理健康状况低于普通人群。LUTS严重程度降低了身心健康状况(p < 0.001)。43%的男性存在临床相关夜尿症(≥ 2次/夜),这降低了身心健康状况(p < O.001),而在无夜间排尿或仅有一次夜间排尿的男性中,两个健康相关生活质量量表均未显著降低。在使用患者报告的LUTS困扰(AUA - SPI)进行的多变量回归分析中,在调查的2年随访期内,仅夜间排尿困扰与就医显著相关(优势比2.6;95%置信区间1.6 - 4.2;p < 0.001)。

结论

我们的研究证实,夜间排尿在社区男性中非常普遍,并会降低身心健康状况。夜间排尿困扰是德国男性LUTS中导致就医的最相关因素。

相似文献

1
Nocturia and its impact on health-related quality of life and health care seeking behaviour in German community-dwelling men aged 50 years or older.夜尿症及其对德国50岁及以上社区居住男性健康相关生活质量和就医行为的影响。
World J Urol. 2014 Oct;32(5):1155-62. doi: 10.1007/s00345-014-1374-6. Epub 2014 Aug 8.
2
Understanding the elements of overactive bladder: questions raised by the EPIC study.了解膀胱过度活动症的要素:EPIC研究提出的问题
BJU Int. 2008 Jun;101(11):1381-7. doi: 10.1111/j.1464-410X.2008.07573.x. Epub 2008 Mar 10.
3
The evaluation of nocturia in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and the analysis of the curative effect after medical or placebo therapy for nocturia: a randomized placebo-controlled study.下尿路症状疑似良性前列腺增生患者夜尿症的评估以及夜尿症药物或安慰剂治疗后的疗效分析:一项随机安慰剂对照研究。
BMC Urol. 2018 Dec 13;18(1):115. doi: 10.1186/s12894-018-0426-4.
4
The patient burden of nocturnal polyuria in the United States: Results from the epidemiology of nocturnal polyuria (EpiNP) study.美国夜间多尿的患者负担:夜间多尿流行病学(EpiNP)研究结果
Neurourol Urodyn. 2023 Mar;42(3):573-585. doi: 10.1002/nau.25126. Epub 2023 Jan 19.
5
The prevalence and risk factors of nocturia in China, South Korea, and Taiwan: results from a cross-sectional, population-based study.中国、韩国和中国台湾地区夜间多尿症的患病率和危险因素:一项基于人群的横断面研究结果。
World J Urol. 2018 Nov;36(11):1853-1862. doi: 10.1007/s00345-018-2329-0. Epub 2018 May 23.
6
Nocturia, Other Lower Urinary Tract Symptoms and Sleep Dysfunction in a Community-Dwelling Cohort of Men.社区居住男性队列中的夜尿症、其他下尿路症状与睡眠功能障碍
Urology. 2016 Nov;97:219-226. doi: 10.1016/j.urology.2016.06.022. Epub 2016 Jun 24.
7
Once nocturia, always nocturia? Natural history of nocturia in older men based on frequency-volume charts: the Krimpen study.一旦出现夜尿症,就会一直存在吗?基于频数-量图的老年男性夜尿症自然史:Krimpen 研究。
J Urol. 2011 Nov;186(5):1956-61. doi: 10.1016/j.juro.2011.07.008. Epub 2011 Sep 23.
8
Survey on prevalence of lower urinary tract symptoms in an Asian population.亚洲人群下尿路症状患病率调查。
Hong Kong Med J. 2019 Feb;25(1):13-20. doi: 10.12809/hkmj187502. Epub 2019 Jan 18.
9
Prevalence, risk factors, and symptom bother of nocturia: a population-based survey in China.夜尿症的患病率、危险因素及症状困扰:一项基于中国人群的调查
World J Urol. 2015 May;33(5):677-83. doi: 10.1007/s00345-014-1411-5. Epub 2014 Sep 26.
10
Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH).去氨加压素对提示良性前列腺增生的下尿路症状(LUTS/BPH)男性患者夜间多尿所致夜尿症的影响。
World J Urol. 2014 Oct;32(5):1163-70. doi: 10.1007/s00345-014-1381-7. Epub 2014 Aug 19.

引用本文的文献

1
Modeling study of the effect of placebo and medical therapy on storage and voiding symptoms, nocturia, and quality of life in men with prostate enlargement at risk for progression.前列腺增生进展风险男性的储存和排尿症状、夜尿症和生活质量的安慰剂和医学治疗效果的建模研究。
Prostate Cancer Prostatic Dis. 2024 Sep;27(3):469-477. doi: 10.1038/s41391-023-00731-w. Epub 2023 Oct 4.
2
[Diagnostic work-up of benign prostatic hyperplasia : The German S2e-guideline 2023 part 1].[良性前列腺增生的诊断检查:2023年德国S2e指南第1部分]
Urologie. 2023 Aug;62(8):805-817. doi: 10.1007/s00120-023-02142-0. Epub 2023 Jul 4.
3
Lower urinary system symptoms and affecting factors in female students staying in a dormitory.

本文引用的文献

1
The prevalence and causes of nocturia.夜尿症的患病率和病因。
J Urol. 2013 Jan;189(1 Suppl):S86-92. doi: 10.1016/j.juro.2012.11.033.
2
Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older.50 岁及以上德国男性社区居民前列腺体积、PSA、最大尿流率、IPSS 及其他下尿路症状/良性前列腺增生症指标的年龄分层正常值。
World J Urol. 2011 Apr;29(2):171-8. doi: 10.1007/s00345-010-0638-z. Epub 2011 Jan 8.
3
The role of nocturia in the quality of life of men with lower urinary tract symptoms.
女大学生宿舍环境下下尿路症状及其影响因素
Rev Assoc Med Bras (1992). 2022 Jul;68(7):922-927. doi: 10.1590/1806-9282.20220058.
4
Review: Correlation between bladder obstruction with bladder function and erectile dysfunction in mice.综述:小鼠膀胱梗阻与膀胱功能及勃起功能障碍之间的相关性
Ann Med Surg (Lond). 2022 Jan 25;75:103294. doi: 10.1016/j.amsu.2022.103294. eCollection 2022 Mar.
5
What Are Realistic Expectations to Become Free of Overactive Bladder Symptoms? Experience from Non-interventional Studies with Propiverine.对于摆脱膀胱过度活动症症状的期望有多现实?普罗苇因非介入性研究的经验。
Adv Ther. 2022 Jun;39(6):2489-2501. doi: 10.1007/s12325-022-02114-4. Epub 2022 Mar 24.
6
Calcium Channel Blockers Are Associated with Nocturia in Men Aged 40 Years or Older.钙通道阻滞剂与40岁及以上男性夜尿症有关。
J Clin Med. 2021 Apr 9;10(8):1603. doi: 10.3390/jcm10081603.
7
[Diagnostic procedures and diagnostic strategy for lower urinary tract symptoms/benign prostatic hyperplasia : An overview].[下尿路症状/良性前列腺增生的诊断程序与诊断策略:概述]
Urologe A. 2019 Mar;58(3):238-247. doi: 10.1007/s00120-019-0870-0.
8
The change of IPSS 7 (nocturia) score has the maximum influence on the change of Qol score in patients with lower urinary tract symptoms.国际前列腺症状评分 7 项(夜尿症)的变化对下尿路症状患者生活质量评分的变化影响最大。
World J Urol. 2019 Apr;37(4):719-725. doi: 10.1007/s00345-018-2410-8. Epub 2018 Aug 2.
9
A practical approach to the management of nocturia.夜尿症管理的实用方法。
Int J Clin Pract. 2017 Nov;71(11). doi: 10.1111/ijcp.13027. Epub 2017 Oct 5.
10
Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies.每日服用50毫克米拉贝隆治疗男性膀胱过度活动症患者的疗效与安全性:五项III期研究的批判性分析
Ther Adv Urol. 2017 May 10;9(6):137-154. doi: 10.1177/1756287217702797. eCollection 2017 Dec.
夜尿症在下尿路症状男性生活质量中的作用。
BJU Int. 2010 Apr;105(7):1016-7; author reply 1017-8. doi: 10.1111/j.1464-410X.2010.09301_1.x.
4
[Diagnostic and differential diagnosis of benign prostate syndrome (BPS): guidelines of the German Urologists].[良性前列腺综合征(BPS)的诊断与鉴别诊断:德国泌尿外科医师指南]
Urologe A. 2009 Nov;48(11):1356-60, 1362-4. doi: 10.1007/s00120-009-2066-5.
5
Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland.夜尿频率、困扰和生活质量:多频繁才算频繁?芬兰一项基于人群的研究。
Eur Urol. 2010 Mar;57(3):488-96. doi: 10.1016/j.eururo.2009.03.080. Epub 2009 Apr 3.
6
[Epidemiology of benign prostatic syndrome. Associated risks and management data in German men over age 50].[良性前列腺综合征的流行病学。50岁以上德国男性的相关风险及管理数据]
Urologe A. 2008 Feb;47(2):141-8. doi: 10.1007/s00120-008-1624-6.
7
[Importance of nocturia and its impact on quality of sleep and quality of life in patient with benign prostatic hyperplasia].[夜尿症的重要性及其对良性前列腺增生患者睡眠质量和生活质量的影响]
Actas Urol Esp. 2007 Mar;31(3):262-9. doi: 10.1016/s0210-4806(07)73632-x.
8
Perception of nocturia and medical consulting behavior among community-dwelling women.社区居住女性对夜尿症的认知及就医行为
Int Urogynecol J Pelvic Floor Dysfunct. 2007 Apr;18(4):431-6. doi: 10.1007/s00192-006-0167-x. Epub 2006 Jul 28.
9
The efficacy of drugs for the treatment of LUTS/BPH, a study in 6 European countries.治疗下尿路症状/良性前列腺增生症药物的疗效:一项在6个欧洲国家开展的研究
Eur Urol. 2007 Jan;51(1):207-15; discussion 215-6. doi: 10.1016/j.eururo.2006.06.012. Epub 2006 Jun 27.
10
Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertise.将下尿路症状/良性前列腺增生患者疾病进展的风险概况纳入治疗选择:外部证据与临床专业知识的综合分析
Prostate Cancer Prostatic Dis. 2005;8(4):369-74. doi: 10.1038/sj.pcan.4500827.